{"nct_id":"NCT01969838","title":"Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2013-12-06","start_date_type":"ACTUAL","primary_completion_date":"2016-09-12","primary_completion_date_type":"ACTUAL","completion_date":"2019-05-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}